Published in Diabetes on March 01, 2004
Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab (2009) 3.98
Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest (2006) 3.76
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet (2008) 2.96
High density lipoprotein: it's not just about lipid transport anymore. Trends Endocrinol Metab (2010) 1.26
The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol (2012) 1.17
Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells. J Lipid Res (2010) 1.11
PAP: a comprehensive workbench for mammalian transcriptional regulatory sequence analysis. Nucleic Acids Res (2007) 1.11
A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes. Mol Cells (2015) 0.87
Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods. Mol Cell Proteomics (2011) 0.84
Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells. J Lipid Res (2013) 0.84
Inflammation and impaired endothelium-dependant vasodilatation in non obese women with gestational diabetes mellitus: preliminary results. Lipids Health Dis (2013) 0.82
Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis. Diabetes Metab Res Rev (2012) 0.80
Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study. Lipids Health Dis (2016) 0.75
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol (2002) 2.55
A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res (2004) 1.67
Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther (2002) 1.27
Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer. Biochem Biophys Res Commun (2004) 1.19
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J Am Coll Cardiol (2010) 1.17
Obesity-related changes in high-density lipoprotein metabolism. Obesity (Silver Spring) (2008) 1.13
Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes (2005) 1.13
Complement is an essential component of the immune response to adeno-associated virus vectors. J Virol (2008) 1.11
Expression of human scavenger receptor B1 on and in human platelets. Arterioscler Thromb Vasc Biol (2003) 1.10
Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes (2002) 1.08
Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem Res (2002) 1.01
The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev (2005) 0.94
Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling. Biochemistry (2006) 0.93
The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology (2002) 0.92
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3. Biochim Biophys Acta (2005) 0.91
Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition (2010) 0.91
A distinct thyroid hormone response element mediates repression of the human cholesterol 7alpha-hydroxylase (CYP7A1) gene promoter. Mol Endocrinol (2002) 0.88
Age-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1). Mech Ageing Dev (2003) 0.88
HDL--is it too big to fail? Nat Rev Endocrinol (2013) 0.86
Glucose-induced endoplasmic reticulum stress is independent of oxidative stress: A mechanistic explanation for the failure of antioxidant therapy in diabetes. Free Radic Biol Med (2011) 0.86
The role of calcium/calmodulin-dependent protein kinase cascade in glucose upregulation of insulin gene expression. Diabetes (2004) 0.85
Arterial embolization: a novel approach to thyroid ablative therapy for Graves' disease. J Clin Endocrinol Metab (2002) 0.85
Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes. Endocrine (2009) 0.84
Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta. Biochim Biophys Acta (2003) 0.84
The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis. Nutr Res (2011) 0.83
Insulin induction of apolipoprotein AI, role of Sp1. Biochemistry (2003) 0.83
High-density lipoprotein is a potential growth factor for adrenocortical cells. Biochem Biophys Res Commun (2006) 0.83
Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells. FEBS Lett (2006) 0.83
Ascorbic acid and alpha-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines. Metabolism (2006) 0.83
Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells. Metabolism (2004) 0.82
Pancreatic glucokinase is activated by insulin-like growth factor-I. Endocrinology (2007) 0.81
24, 25-dihydroxycholecalciferol but not 25-hydroxycholecalciferol suppresses apolipoprotein A-I gene expression. Life Sci (2010) 0.80
Endoplasmic reticulum stress in HepG2 cells inhibits apolipoprotein A-I secretion. Life Sci (2012) 0.80
Regulation of scavenger receptor class BI gene expression by angiotensin II in vascular endothelial cells. Hypertension (2007) 0.80
Prion infected meat-and-bone meal is still infectious after biodiesel production. PLoS One (2008) 0.80
Thyrotropin-releasing hormone-stimulated thyrotropin expression involves islet-brain-1/c-Jun N-terminal kinase interacting protein-1. Endocrinology (2004) 0.80
The effect of glucosamine on Serum HDL cholesterol and apolipoprotein AI levels in people with diabetes. Diabetes Care (2007) 0.79
The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects. Growth Horm IGF Res (2006) 0.79
Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators. Biochim Biophys Acta (2007) 0.79
Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids. Obesity (Silver Spring) (2011) 0.79
Hyperglycemia suppresses hepatic scavenger receptor class B type I expression. Am J Physiol Endocrinol Metab (2007) 0.79
Stilbene analogs as inducers of apolipoprotein-I transcription. Eur J Med Chem (2010) 0.78
Inhibition of apolipoprotein A-I expression by TNF-alpha in HepG2 cells: requirement for c-jun. J Cell Biochem (2014) 0.78
Insulin-like growth factor-i regulation of hepatic scavenger receptor class BI. Endocrinology (2004) 0.78
Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells. Diabetes Res Clin Pract (2009) 0.78
Role of calcium-calmodulin-dependent protein kinase cascade in thyrotropin (TSH)-releasing hormone induction of TSH and prolactin gene expression. Endocrinology (2004) 0.77
Cyclosporin A inhibits apolipoprotein AI gene expression. J Mol Endocrinol (2006) 0.77
Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: a potential mechanism for smoking-associated hypoalphalipoproteinemia. Life Sci (2012) 0.77
Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus. Neurosci Lett (2004) 0.77
Saturated, unsaturated, and trans-fatty acids modulate oxidative burst induced by high dextrose in human umbilical vein endothelial cells. Nutrition (2006) 0.77
Pubertal changes in serum leptin levels in adolescents with type 1 diabetes mellitus: a controlled longitudinal study. J Pediatr Endocrinol Metab (2004) 0.76
The effect of nutritional supplements on serum high-density lipoprotein cholesterol and apolipoprotein A-I. Am J Cardiovasc Drugs (2014) 0.76
Induction of the apolipoprotein AI promoter by Sp1 is repressed by saturated fatty acids. Metabolism (2004) 0.76
Induction of apolipoprotein A-I gene expression by glucagon-like peptide-1 and exendin-4 in hepatocytes but not intestinal cells. Metabolism (2012) 0.76
Effect of chromium on apolipoprotein A-I expression in HepG2 cells. Nutrition (2003) 0.76
Towards single-tablet therapy for type 2 diabetes mellitus. Rationale and recent developments. Treat Endocrinol (2004) 0.76
Lipid-altering drugs: decreasing cardiovascular disease at the expense of increasing cancer? Cancer Res (2004) 0.75
Suppression of hyperglycemia-induced superoxide formation and endothelin-1 gene expression by carvedilol. Am J Ther (2006) 0.75
Effects of dehydroepiandrosterone on rat apolipoprotein AI gene expression in the human hepatoma cell line, HepG2. Metabolism (2002) 0.75
Thermal decomposition of matrix metalloproteinase inhibitors: evidence of solid state dimerization. J Pharm Biomed Anal (2010) 0.75
Statins ameliorate glomerular permeability changes in streptozotocin-induced diabetic rats. Am J Ther (2007) 0.75
The thyroid hormone responsive protein (THRP) has a critical role in the embryogenesis of Xenopus laevis. Neurosci Lett (2010) 0.75
Statins Prevent Dextrose-Induced Endoplasmic Reticulum Stress and Oxidative Stress in Endothelial and HepG2 Cells. Am J Ther (2014) 0.75
Targeting high-density lipoproteins: increasing de novo production versus decreasing clearance. Drugs (2015) 0.75
PREB regulates transcription of pancreatic glucokinase in response to glucose and cAMP. J Cell Mol Med (2009) 0.75
Primary hyperparathyroidism and vitamin D in African Americans. Endocr Pract (2012) 0.75
The isolation and identification of a toxic impurity in XP315 drug substance. J Pharm Biomed Anal (2002) 0.75
The Effects of Known Cardioprotective Drugs on Proinflammatory Cytokine Secretion From Human Coronary Artery Endothelial Cells. Am J Ther (2017) 0.75
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery disease. J Cardiovasc Transl Res (2013) 0.75
Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts. Pharm Biol (2014) 0.75
Rapid adaptive down regulation of oxidative burst induced by high dextrose in human umbilical vein endothelial cells. Diabetes Res Clin Pract (2004) 0.75
Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2. Metabolism (2004) 0.75
Apolipoprotein A-I expression in rats is not altered by troglitazone. Exp Biol Med (Maywood) (2002) 0.75